NCT05997043View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 26, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2026

Conditions
Parkinson's DiseaseOveractive BladderOnabotulinumtoxin A
Interventions
DRUG

oral anti-Parkinson drugs and injection of botulinum toxin

The experimental group was treated with oral anti-Parkinson drugs and injection of botulinum toxin

DRUG

oral anti-Parkinson's drugs

The control group only took oral anti-Parkinson's drugs.

Trial Locations (1)

510000

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER